The presence of microalbuminuria has become an important tool for therapeutic intervention. In this study we investigated whether the dysmetabolic syndrome of obesity was associated with or could occur in the absence of microalbuminuria. The study was conducted in 71 clinically healthy, glucose tolerant Hispanics (age: 43 ؎ 1.4 years, body mass index (BMI): 28.7 ؎ 0.6 kg/m 2 , systolic blood pressure (SBP): 117 ؎ 2 mm Hg, diastolic blood pressure (DBP): 77 ؎ 1.3 mm Hg, urinary albumin excretion: 10.2 ؎ 0.6 mg/24 h). Subjects were classified as lean (BMI Ͻ25), overweight (BMI Ͼ25 Ͻ30) and obsese (BMI Ͼ30 kg/m 2 ). Greater BMI was associated with higher body weight, waist-to-hip ratio (WHR), BP, fasting insulin, triglyceride, post glucose load insulin and glucose, and lower high-density lipoprotein (HDL) cholesterol levels. However, no significant differences in the urinary albumin excretion (mg/24 h) were found between lean (9.0 ؎ 0.9; median: 9.1), overweight (11.3 ؎ 1.2; median: 10.5) and obese (11.1 ؎ 1.2; median: 9.7) subjects. In addition, microalbuminuria
Introduction
The presence of microalbuminuria has become an important tool for therapeutic intervention. 1, 2 In type 1 and type 2 diabetes, microalbuminuria is an early sign of an increased risk for developing kidney (urinary albumin excretion Ͼ30 mg/24 h) was not found in any of the study subjects. For all subjects combined, as well as for each of the groups separately, the urinary albumin excretion was unrelated to the BMI, WHR, body weight, triglyceride, cholesterol (total, LDL or HDL), fasting or post-load glucose and insulin plasma concentrations. Neither in females nor in males, abdominal fat accumulation was associated with an increase in the urinary albumin excretion. However, in the obese groups, urinary albumin excretion was strongly related to the level of SBP (r 2 : 0.67; P Ͻ 0.0001) and DBP (r 2 : 0.55; P Ͻ 0.0001). In summary, obesity, hyperinsulinaemia and dyslipidaemia per se are not determinants of increased albumin excretion. However, in the obese subjects, the BP, particularly the SBP, was a strong determinant of the level of albumin in the urine. Microalbuminuria may occur later in the course of the dysmetabolic syndrome, due to worsening of hypertension and development of hyperglycaemia.
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and cardiovascular disease. [3] [4] [5] [6] [7] Moreover, it has been reported that even in non-diabetic subjects the presence of microalbuminuria may be associated with increased atherosclerotic risk factors and cardiovascular morbidity and mortality. [8] [9] [10] [11] However, what determines microalbuminuria in normotensive nondiabetic subjects is unknown.
Insulin resistance is the major pathophysiological defect in most cases of type 2 diabetes and is the hallmark of the dysmetabolic cardiovascular syndrome. 12, 13 This syndrome is characterised by obesity, dyslipidaemia, impaired glucose tolerance and hypertension associated with marked insulin resist-
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ance and compensatory hyperinsulinaemia. 12 Since the development of cardiovascular risk begins even before the appearance of clinical diabetes and is related to the presence of insulin resistance, 4 it has been proposed that microalbuminuria would be present earlier in the disease process.
14,15 However, how early and which of the dysmetabolic risk factors is best associated with microalbuminuria is unknown. It is also possible that racial factors may play a role. In this study, we evaluated in clinically healthy Hispanic subjects whether obesity, abdominal fat deposition, subject's blood pressure (BP), extent of dyslipidaemia and hyperinsulinaemia are associated with microalbuminuria or could occur in the absence of microalbuminuria. The possible existence of a relationship between each of the risk factors or their combination and presence of microalbuminuria was investigated. To avoid the effects of hyperglycaemia, the study was conducted in glucose tolerant individuals.
Materials and methods
A total of 71 subjects attending our Center for the Detection and Treatment of Silent Cardiovascular Risk Factors (Central University of Venezuela) were evaluated. The exclusion criteria were: age greater than 70 years; a history of angina pectoris, myocardial infarction, congestive heart failure, valvular heart disease, cerebral infarction or haemorrhage, transient ischaemic attacks, arteriosclerosis obliterans or pulmonary disease; any patient with active disease, evidences of renal or hepatic dysfunction, active inflammatory disease states, severe hypertension, impaired glucose tolerance of diabetes mellitus; women on birth control pills, and subjects with serum creatinine concentration greater than 2 mg/dl.
Body mass index (BMI) was calculated as body weight in kg/height in meters squared (kg/m 2 ). 16 Waist and hip circumferences in centimeters were measured at the level of the umbilicus and at the broadest level of the trocanteric region, respectively. The ratio of waist-to-hip girth was calculated (WHR). BP was determined by sphygmomanometry after the patient had rested 30 min in supine position. Korotkoff sounds 1 and 5 were used to record systolic (SBP) and diastolic (DBP), respectively. 
Statistics
Continuous variables were compared by analysis of variance (ANOVA) followed by a post-hoc analysis by means of the Duncan's test. Two-sample comparison was analysed with the Student's t-test. For variables not following a Gaussian distribution, log transformation and/or non-parametric analyses (Mann-Whitney two-sample test) were performed. Because of the positive skewed distributions, urinary albumin excretion and triglycerides were expressed as medians and were log-transformed before statistical processing. The other variables are shown as mean values Ϯ s.e.m.; differences were considered significant at values of P Ͻ 0.05.
Results
Our study population consisted of 71 clinically healthy hispanic subjects (46 F, 25 M) of 43 Ϯ 1.4 years of age and of an average BMI of 28.7 Ϯ 0.6 kg/m 2 . The urinary sodium excretion averaged 146 Ϯ 8 mEq/24 h. SBP and DBP averaged 117 Ϯ 2 and 77 Ϯ 1.3 mm Hg, respectively. Fasting plasma glucose was 4.7 Ϯ 0.05 mmol/l (85 Ϯ 1 mg/dl) and fasting plasma insulin 21 Ϯ 2 U/dl. All subjects had fasting glucose levels below 6.1 mmol/l (110 mg/dl). Two hours after oral ingestion of 75 g of glucose, plasma glucose concentrations averaged 5.5 Ϯ 0.1 mmol/L (99 Ϯ 2 mg/dL) and all subjects have values below 7.8 mmol/L (140 mg/dL). All subjects were glucose tolerant. No individuals had an urinary albumin excretion greater than 30 mg/24 h, the level accepted for microalbuminuria. The mean urinary albumin excretion averaged 10.2 Ϯ 0.6 mg/ 24 h (9.5 median). For all patients, no significant relationships were observed between the urinary albumin excretion (log transformed) and BMI, WHR, fasting glucose, post-load glucose, fasting insulin, post-load insulin, total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol and log-transformed triglycerides (data not shown). A significant (P = 0.0006) correlation was observed between urinary albumin excretion (log) and SBP. For DBP, the association with albuminuria was weaker than for SBP, although significant (P = 0.015).
Subjects were classified as lean, overweight and obese according to their BMI. 16 Higher BMI were associated with greater body weight and WHR ratios. Lean subjects (BMI lower than 25 kg/m 2 ) had significantly lower weights and WHR than overweight and obese subjects (Table 1) . Obesity was associated with higher BPs and higher fasting and post glucose insulin levels. Fasting glucose levels were not different between groups; although, the 2-h glucose levels during the oral glucose tolerance test were modestly increased in the obese, compared to the overweight and lean subjects. Lower HDL cholesterol and higher triglyceride concentrations were observed in overweight (Ͼ25 to Ͻ30 kg/m 2 ) and obese (Ͼ30 kg/m 2 ) subjects compared to lean individuals. Therefore, as the BMI increased, body weight, waist circumference, WHR, BP, insulin and triglycerides levels increased and HDL levels decreased (Table 1) . Despite the marked anthropometric, BP and metabolic differences observed between the study groups, comparable values for the urinary albumin excretion were found in lean, overweight and obese subjects (Table 1) . Median values for the urinary albumin excretion were 9.1, 10.5 and 9.7 (mg/24 h) in lean, overweight and obese subjects, respectively. For each of the groups, the urinary albumin excretion was unrelated to the waist circumference, WHR, or body weight, BMI, plasma triglyceride or cholesterol (total, LDL or HDL) levels, or the fasting or post-load glucose and insulin concentrations (data not shown). However, in the obese subjects, urinary albumin excretion was strongly associated with the level of SBP (r 2 : 0.676; P Ͻ 0.0001) and DBP (r 2 : 0.55; P Ͻ 0.0001) ( Figure  1 ). This association was not found in lean or overweight subjects, despite the fact that the urinary albumin level of these two groups was not different from that of the obese individuals.
To investigate the possible role of gender-related differences in abdominal obesity on urinary albumin
Journal of Human Hypertension Figure 1 Relationship between systolic blood pressure and the urinary excretion of albumin in obese, glucose tolerant subjects. A linear regression analysis was performed between systolic blood pressures (mm Hg) and the log-transformed urinary albumin excretion in obese (BMI Ͼ30 kg/m 2 ), glucose tolerant individuals. A strong positive and highly significant relationship was observed between these two variables.
excretion, patients were classified by gender and by WHR, as suggested. 2 Females were divided in two groups, those with WHR р0.85 and those with WHR у0.85 (Table 2 ). Males were also classified according to their WHR, employing a value of 1 as the cutoff point (Table 3) . Both, for females and males, abdominal obesity was associated with slightly older age, higher BMI, weight, BP, fasting and 2-h post-load insulin levels, lower HDL cholesterol (in females not in males) and higher triglyceride levels. No relationship between urinary albumin excretion and WHR or with any of the other risk factors present in the subjects with higher WHR, was observed. In addition, similar levels of albuminuria Data are means ± s.e.m. *P Ͻ 0.05; **P Ͻ 0.01 vs lean. Values within parenthesis are medians. Glucose: to convert mg/dl to mmol/l, multiply by 0.055506. Triglycerides: to convert mg/dl to mmol/l, multiply by 0.01129. HDL and LDL cholesterol: to convert to mg/dl to mmol/l, multiply by 0.02586.
were observed in males and females, irrespectively of their WHR (Tables 2 and 3) . Similar results were observed if a BMI of 0.93 was employed as the cutoff point for WHR in males (data not shown).
Discussion
We report no evidence for microalbuminuria in obese, glucose tolerant Hispanics. We found comparable levels of albuminuria in lean, overweight and obese glucose tolerant subjects, despite the fact that plasma insulin levels increased in proportion with the increase in BMI, body weight and WHR. Fasting insulinaemia and glucose-induced insulinaemia were much greater in obese than in lean subjects, supporting the view that obesity is associated with fasting and post-load hyperinsulinaemia. 13, 17 Although neither measurement is a direct estimate of insulin resistance, fasting and post-load hyperinsulinaemia of obesity are known to be the consequence of a state of insulin resistance. 13, [17] [18] [19] Since comparable urinary albumin excretion was encountered in hyperinsulinaemic and 'normoinsulinaemic' subjects (lean subjects), hyperinsulinaemia and possibly insulin resistance of obesity seems not to be a determinant of increased albuminuria, at least in glucose tolerant subjects. This is also supported by the observation that the level of albuminuria was unrelated to fasting or post glucose insulinaemia. Our findings suggest that hyperinsulinaemia is not a determinant factor in increasing albuminuria. A similar reasoning is valid for the dyslipidaemia of overweight and obesity. Both elevated triglycerides and low HDL cholesterol were not associated with greater albuminuria, and no relationship between these variables was observed. Interestingly, similar urinary albumin excretion was observed in insulin resistant hypertensives and in insulin sensitive normotensives, 20 suggesting that hypertension and insulin resistance can occur independently of increased albuminuria. In addition, no association between albuminuria and insulinaemia was encountered in hypertensive and atherosclerotic men. 21 These observations suggest that hyperinsulinaemia and insulin resistance are not necessarily associated with increased urinary albumin excretion, at least in glucose tolerant normotensive or hypertensive individuals (present study). 20, 21 Not observing microalbuminuria despite the presence of multiple cardiovascular risk factors may be due to the absence of hyperglycaemia. Although the obese subjects had higher glucose and insulin levels during the oral tolerance test than the non-obese, none of the study subjects had impaired glucose tolerance. 22 Consequently, hyperglycaemia seems to play an important role in determining the glomerular damage and hyperfiltration responsible for the microalbuminuria. Increased albuminuria may occur later in the course of the insulin resistance syndrome, when the insulin secretion fails to compensate for insulin resistance, leading to hyperglycaemia. In favour of this view, are the observations indicating that tighter blood glucose control reduces the incidence and progression of cardiovascular complications and of diabetic nephropathy. 7, 23, 24 In addition, subsequent development of hypertension and/or worsening or existing hypertension elevation of the BP, and development of a state of salt sensitivity, may also play a role in the development of microalbuminuria. 25 Because of the well-known male and female pattern of body fat distribution, 16 we separately evaluated the relationships between abdominal fat and albuminuria in males and females. In both, female and male subjects, the elevation of BP, insulin and triglyceride levels associated with obesity or abdominal obesity was not accompanied with increases in urinary albumin excretion. Interestingly, when intra-abdominal fat mass and total body fat mass were assessed by whole-body dual energy X-ray absorptiometry scanning and abdominal computed tomography scanning, no correlation was observed between visceral fat accumulation and urinary albumin excretion in young, normal glucose tolerant, female and male Caucasians. 26 This observation, together with our findings indicate that abdominal obesity is not a determinant per se of increased urinary albumin excretion.
A strong relationship between albuminuria and the BP level (particularly SBP) was found for the group of individuals with BMI greater than 30 kg/m 2 (obese); although the albumin excretion was below the levels for microalbuminuria. No relationship between BP and albuminuria was observed in subjects with BMI Ͻ30 (lean and/or overweight), possibly because of the lower BP and smaller range of BP values in the non-obese individuals. It is feasible that a threshold haemodynamic load is required to observe a relationship between urinary albumin excretion and BP. Higher albuminuria has been reported in hypertensive compared to normotensive individuals, 25 and SBP has been shown to correlate with urinary albumin in microalbuminuric hypertensive patients. 21 These findings suggest that elevated SBP is an important determinant of the urinary albumin excretion (present study). 21, 25 The higher BP of obese compared to lean may be responsible for the existence of a relationship between BP and urinary albumin excretion in the obese group.
A relationship between microalbuminuria and salt-sensitive hypertension has been previously demonstrated in hypertensive subjects. 27 Such a possibility was not evaluated in our study. The average salt intake of our study population was rather high in the order of 145 mEq/day. BP may thus be increased in salt sensitive subjects due to high salt intake. Therefore, we can not rule out that the positive relationship observed between SBP and albuminuria could be due to greater reactivity to salt of some of the obese individuals.
Conclusion
Our results indicate that dysmetabolic risk factors may occur independently of microalbuminuria in obese, glucose tolerant individuals, and that neither Journal of Human Hypertension hyperinsulinaemia, dyslipidaemia nor abdominal obesity determines the level of albuminuria. Increased albuminuria may occur later when hyperglycaemia and hypertension develop. In obese subjects, BP levels and in particular SBP, were found strong determinants of the level of albuminuria. Finally, our study further stresses the coexistence of risk factors for diabetes and cardiovascular disease in overweight and obese individuals, even if the subjects are glucose tolerant and have blood pressures within the normotensive range. 28, 29 
